SA vaccine trial volunteers contributing to AIDS fight

A number of potential HIV vaccines have made it out of the laboratory, but clinical trials on humans are still only in the second of three phases. The primary goals in the current round of trials are to establish safety, dosage and their ability to trigger an immune response.

Thandi Nxamakele, 27, from Klerksdorp, a gold mining town in South Africa's North West Province, was one of 240 South Africans who took part in a phase II HIV vaccine trial conducted by the Aurum Institute for Health Research, an independent medical scientific organisation.

Read the article here